Clinical trial
The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced…
NCT00449813 · Takeda, Industry · Terminated
Key facts
| NCT number | NCT00449813 |
|---|---|
| Title | The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511) |
| Official title | The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms |
| Lead sponsor | Takeda, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux Disease, Non-erosive Reflux Disease |
| Intervention type | Drug |
| Interventions | Pantoprazole |
| Enrollment | 40 |
| Start date | Mar 1, 2007 |
| Primary completion | Oct 1, 2007 |
| Completion | Nov 1, 2008 |
| First posted | Mar 21, 2007 |
| Last update posted | May 7, 2012 |
| Countries | Netherlands, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: